Edition:
India

Ankur Banerjee

Regeneron, Sanofi arthritis drug fails COVID-19 study

03 Jul 2020

Regeneron Pharmaceuticals Inc and Sanofi said on Thursday their rheumatoid arthritis drug Kevzara failed to meet the main goals of a U.S. study testing it in the most critically ill COVID-19 patients.

US STOCKS-Wall Street gains on vaccine hopes, improving economic data

01 Jul 2020

* Early positive results for Pfizer, BioNTech vaccine candidate

Rare syndrome linked to COVID-19 found in almost 300 U.S. kids, adolescents

30 Jun 2020

Nearly 300 cases of a rare, life-threatening syndrome in children and adolescents associated with the novel coronavirus have been identified in the United States in two studies in The New England Journal of Medicine.

Young U.S. men having a lot less sex in the 21st century, study shows

13 Jun 2020

Sexual activity among young American men has declined sharply since 2000, with nearly a third reporting no sex with a partner in the prior year, according to a survey study published on Friday that suggests social media and electronic gaming might be filling the void.

Drug touted by Trump to treat COVID-19 linked to higher death risk - study

23 May 2020

The anti-malarial drug hydroxychloroquine, which U.S. President Donald Trump says he has been taking and has urged others to use, was tied to an increased risk of death in hospitalized COVID-19 patients, a large study published on Friday showed. | Video

Trump administration signs up new company to make COVID-19 drugs in U.S.

20 May 2020

U.S. President Donald Trump's administration awarded a contract worth up to $812 million for a new U.S. company to manufacture drugs and drug ingredients to fight COVID-19 on American soil, aiming to end dependence on other countries.

Trump administration awards contract to make COVID-19 drugs in U.S.

19 May 2020

By Michael Erman and Ankur Banerjee U.S. President Donald Trump's administration awarded a contract worth up to $812 million for a new U.S. company to manufacture drugs and drug ingredients to fight COVID-19 on American soil, aiming to end dependence on other countries.

Thermo Fisher agrees to buy genetic tester Qiagen in $11.5 billion deal

03 Mar 2020

FRANKFURT/NEW YORK Thermo Fisher Scientific Inc said on Tuesday it agreed to acquire German genetic testing company Qiagen NV in an $11.5 billion deal as the U.S.-based company looks to bolster its health diagnostic business. | Video

Indian generic drugmakers may face supply shortages from China if coronavirus drags on

14 Feb 2020

Shortages and potential price increases of generic drugs from India loom if the coronavirus outbreak disrupts suppliers of pharmaceutical ingredients in China past April, according to industry experts.

Indian generic drugmakers may face supply shortages from China if coronavirus drags on

14 Feb 2020

Shortages and potential price increases of generic drugs from India loom if the coronavirus outbreak disrupts suppliers of pharmaceutical ingredients in China past April, according to industry experts.

World News